MediWound outlines $24M-$26M 2026 revenue target while expanding EscharEx clinical programs
Source: SeekingAlpha
2026-03-05 16:56:55 ET
More on MediWound
- MediWound Ltd. (MDWD) Q4 2025 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on MediWound
- Historical earnings data for MediWound
- Financial information for MediWound
Read the full article on Seeking Alpha
For further details see:
MediWound outlines $24M–$26M 2026 revenue target while expanding EscharEx clinical programs
MediWound Ltd.
NASDAQ: MDWD
MDWD Trading
-0.92% G/L:
$17.30 Last:
15,498 Volume:
$17.38 Open:
MDWD Latest News
MDWD Stock Data
$198,368,635
8,315,055
N/A
24
N/A
Biotechnology & Life Sciences
Healthcare
IL
Yavne
